Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
BMJ Open. 2019 Sep 5;9(9):e027144. doi: 10.1136/bmjopen-2018-027144.
Texture analysis (TA) is a method used for quantifying the spatial distributions of intensities in images using scanning software. MRI TA could be applied to grade gliomas. This meta-analysis was performed for assessing the accuracy of MRI TA in differentiating low-grade gliomas from high-grade ones.
PubMed, Cochrane Library, Science Direct and Embase were searched for identifying suitable studies from their inception to 1 September 2018. The quality of the studies was evaluated on the basis of the Quality Assessment of Diagnostic Accuracy Studies guidelines. We estimated the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic OR (DOR) using the summary receiver operating characteristic (SROC) for identifying the accuracy of MRI TA in grading gliomas. Fagan nomogram was applied for assessing the clinical utility of TA.
Six studies including 440 patients were included and analysed. The pooled sensitivity, specificity, PLR, NLR and DOR with 95% CIs were 0.93 (95% CI 0.88 to 0.96), 0.86 (95% CI 0.81 to 0.89), 6.4 (95% CI 4.8 to 8.6), 0.08 (95% CI 0.05 to 0.15) and 78 (95% CI 39 to 156), respectively. The SROC curve showed an area under the curve of 0.96 (95% CI 0.93 to 0.97). Deeks test confirmed no significant publication bias in all studies. Fagan nomogram revealed that the post-test probability increased by 43% in patients with positive pre-test.
The findings of this meta-analysis suggested that MRI TA has high accuracy in differentiating low-grade gliomas from high-grade ones. A standardised methodology is warranted to guide the use of this technique for clinical decision-making.
纹理分析(TA)是一种使用扫描软件量化图像中强度空间分布的方法。MRI TA 可用于胶质瘤分级。本荟萃分析旨在评估 MRI TA 区分低级别和高级别胶质瘤的准确性。
从建库至 2018 年 9 月 1 日,我们通过 PubMed、Cochrane Library、Science Direct 和 Embase 检索合适的研究。根据诊断准确性研究质量评估指南评估研究质量。我们使用汇总受试者工作特征(SROC)估计 MRI TA 识别胶质瘤分级准确性的合并敏感性、特异性、阳性似然比(PLR)、阴性似然比(NLR)和诊断比值比(DOR)。Fagan 列线图用于评估 TA 的临床实用性。
纳入并分析了 6 项研究共 440 例患者。合并敏感性、特异性、PLR、NLR 和 DOR 的 95%置信区间分别为 0.93(95% CI 0.88 至 0.96)、0.86(95% CI 0.81 至 0.89)、6.4(95% CI 4.8 至 8.6)、0.08(95% CI 0.05 至 0.15)和 78(95% CI 39 至 156)。SROC 曲线下面积为 0.96(95% CI 0.93 至 0.97)。Deeks 检验证实所有研究均无显著发表偏倚。Fagan 列线图显示,阳性预测值患者的后测概率增加了 43%。
本荟萃分析结果表明,MRI TA 区分低级别和高级别胶质瘤具有较高的准确性。需要标准化的方法来指导该技术在临床决策中的应用。